GNH USA

Europe — EMA

Octaplex

GNH USA supplies Octaplex (Human Coagulation Factor IX), a coagulation factor concentrate for hemophilia B and related bleeding disorders.

Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Human Coagulation Factor IX, the active ingredient in Octaplex, is a coagulation factor concentrate presented as a sterile solution for intravenous use. It is used to replace deficient factor IX in patients with hemophilia B and other bleeding disorders. GNH USA supplies Octaplex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F used for?

Octaplex is a coagulation factor concentrate that addresses deficiencies in the intrinsic clotting pathway, primarily used for hemophilia B and related bleeding conditions. - Hemophilia B: provides factor IX replacement to control and prevent bleeding episodes. - Acquired factor IX deficiency: restores clotting ability in patients with acquired deficiency. - Surgical prophylaxis: reduces peri‑operative bleeding risk in patients with factor IX deficiency. - Trauma‑induced bleeding: supplies rapid factor IX to manage acute hemorrhage in deficient individuals.

What are the side effects of Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Infusion site pain or erythema - Headache - Fever or chills - Nausea - Arthralgia - Mild hypertension

Serious or Rare Side Effects: - Thromboembolic events (deep vein thrombosis, pulmonary embolism) - Anaphylactic or severe hypersensitivity reactions - Development of factor IX inhibitors - Viral transmission (theoretical risk from plasma‑derived product) - Renal impairment or hemolysis - Severe hypertension or cardiovascular instability

What precautions apply to Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F?

Octaplex requires careful clinical monitoring and adherence to safety guidelines. - Inhibitor monitoring: assess for development of factor IX antibodies during therapy. - Thrombosis risk: evaluate patient history for thromboembolic disorders before use. - Viral safety: ensure product sourced from screened donors and processed with viral inactivation steps. - Hypersensitivity: avoid in patients with known allergy to any component of the preparation. - Renal/hepatic impairment: adjust dosing and monitor organ function as needed. - Storage: Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F interact with?

Octaplex can interact with other medications affecting hemostasis and immune response.

Major Interactions (Avoid): - Concurrent anticoagulants (warfarin, heparin): may increase bleeding risk. - Other pro‑coagulant agents (e.g., activated prothrombin complex concentrates): heighten thrombosis potential.

Moderate Interactions (Monitor Closely): - Immunosuppressive drugs (cyclosporine, azathioprine): may affect inhibitor development. - Live vaccines: potential altered immune response; consider timing of administration. - Antibiotics affecting gut flora: monitor for changes in vitamin K status influencing coagulation.

Frequently asked questions

What is Octaplex used for?+
Octaplex is a plasma‑derived coagulation factor concentrate that provides human factor IX to treat and prevent bleeding in patients with hemophilia B, acquired factor IX deficiency, and during surgical or traumatic situations where clotting support is required.
How does Human Coagulation Factor IX work in Octaplex?+
The factor IX in Octaplex replaces the missing or deficient protein in the intrinsic clotting pathway. Once administered, it is activated to factor IXa, which partners with factor VIIIa to convert factor X to factor Xa, leading to thrombin generation and formation of a stable fibrin clot.
What is the usual dose of Octaplex?+
Dosing of Octaplex is individualized and determined by the prescribing clinician based on the patient’s factor IX activity level, severity of bleeding, body weight, and clinical situation. The prescriber calculates the required units to achieve target clotting levels.
Is Octaplex safe during pregnancy or breastfeeding?+
Octaplex may be used in pregnancy or lactation only if clearly needed and after careful risk‑benefit assessment by the treating physician. Limited data are available, so clinicians should monitor both mother and infant closely for any adverse effects.
How do I order Octaplex from GNH USA?+
To order Octaplex, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling), and necessary import documentation.
How does Octaplex compare with other factor IX products?+
Octaplex is a plasma‑derived factor IX concentrate containing additional plasma proteins, whereas recombinant factor IX products are virus‑inactivated and free of plasma proteins. Clinical efficacy is comparable, but the choice may depend on patient tolerance, inhibitor status, and specific safety considerations.
What are the storage and handling requirements for Octaplex?+
Octaplex must be stored refrigerated at 2‑8 °C, protected from light, and should never be frozen or shaken. Before administration, the vial should be inspected for particulates and allowed to reach room temperature if required by the label.
How is Octaplex administered?+
Octaplex is supplied as a sterile solution for intravenous infusion. It is typically administered by slow IV push or infusion under aseptic conditions, following the dosing instructions provided by the prescribing clinician.
What are the most serious risks associated with Octaplex?+
The most serious risks include development of factor IX inhibitors, thromboembolic events such as deep‑vein thrombosis or pulmonary embolism, severe hypersensitivity or anaphylaxis, and the theoretical risk of viral transmission despite rigorous donor screening and viral inactivation processes.
Who should not use Octaplex?+
Octaplex should not be used in individuals with known hypersensitivity to any component of the product, in patients with active uncontrolled thrombosis, or in those who have previously developed high‑titer inhibitors to factor IX without appropriate medical supervision.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Human Coagulation Factor Ix, Protein C, Human Coagulation Factor Vii, Protein S, Human Coagulation F
Route
Intravenous Use
Manufacturer
Octapharma Gmbh
Origin
EU